Literature DB >> 10692239

IL-12-Dependent enhancement of CTL response to weak class I-restricted peptide immunogens requires coimmunization with T helper cell immunogens.

H Swiniarski1, S F Wolf, K Sturmhoefel, R L Peterson, A J Dorner, M O'Toole.   

Abstract

The effect of in vivo administration of rmIL-12 on the CTL response to immunization with a weakly immunogenic class I-restricted peptide emulsified in incomplete Freund's adjuvant was investigated. In the absence of IL-12, peptide-specific CTL responses were significantly greater following coimmunization with class I-restricted peptide and T helper cell antigens than following immunization with the class I-restricted peptide alone. IL-12-dependent enhancement of the CTL response to peptide immunization was demonstrated in the presence of, but not in the absence of, coimmunization with T helper cell antigen. These findings indicate that IL-12 enhancement of the CTL response to weak class I-restricted immunogens is T helper cell dependent. Treatment with rmIL-12 also enhanced the CTL response to immunization with cDNA encoding both CTL and T helper cell epitopes. These findings are relevant to the design of vaccines containing tumor-associated class I-restricted peptides currently being tested as an immunotherapy for cancer patients. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10692239     DOI: 10.1006/clim.2000.4836

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  2 in total

1.  Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responses.

Authors:  K Lee; W W Overwijk; M O'Toole; H Swiniarski; N P Restifo; A J Dorner; S F Wolf; K Sturmhoefel
Journal:  J Interferon Cytokine Res       Date:  2000-06       Impact factor: 2.607

2.  Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.

Authors:  James W Peacock; Sushila K Nordone; Shawn S Jackson; Hua-Xin Liao; Norman L Letvin; Alicia Gomez Yafal; Linda Gritz; Gail P Mazzara; Barton F Haynes; Herman F Staats
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.